Literature DB >> 15526343

A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers.

Teck Yew Low1, Chon Kar Leow, Manuel Salto-Tellez, Maxey C M Chung.   

Abstract

Thioacetamide (TAA) administration is an established technique for generating rat models of liver fibrosis and cirrhosis. Oxidative stress is believed to be involved as TAA-induced liver fibrosis is initiated by thioacetamide S-oxide, which is derived from the biotransformation of TAA by the microsomal flavine-adenine dinucleotide (FAD)-containing monooxygense (FMO) and cytochrome P450 systems. A two-dimensional gel electrophoresis-mass spectrometry approach was applied to analyze the protein profiles of livers of rats administered with sublethal doses of TAA for 3, 6 and 10 weeks respectively. With this approach, 59 protein spots whose expression levels changed significantly upon TAA administration were identified, including three novel proteins. These proteins were then sorted according to their common biochemical properties and functions, so that pathways involved in the pathogenesis of rat liver fibrosis due to TAA-induced toxicity could be elucidated. As a result, it was found that TAA-administration down-regulated the enzymes of the primary metabolic pathways such as fatty acid beta-oxidation, branched chain amino acids and methionine breakdown. This phenomenon is suggestive of the depletion of succinyl-CoA which affects heme and iron metabolism. Up-regulated proteins, on the other hand, are related to oxidative stress and lipid peroxidation. Finally, these proteomics data and the data obtained from the scientific literature were integrated into an "overview model" for TAA-induced liver cirrhosis. This model could now serve as a useful resource for researchers working in the same area.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526343     DOI: 10.1002/pmic.200400852

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  30 in total

Review 1.  Immune mechanisms of Concanavalin A model of autoimmune hepatitis.

Authors:  Hai-Xia Wang; Man Liu; Shun-Yan Weng; Jing-Jing Li; Chao Xie; Hong-Lin He; Wen Guan; Yun-Sheng Yuan; Jin Gao
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

2.  Effect of epigallocatechin gallate on uncoupling protein 2 in acute liver injury.

Authors:  Mohammad H Jamal; Hamad Ali; Ali Dashti; Jasim Al-Abbad; Husain Dashti; Chako Mathew; Waleed Al-Ali; Sami Asfar
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.

Authors:  Yoshiyuki Takahara; Mitsuo Takahashi; Hiroki Wagatsuma; Fumihiko Yokoya; Qing-Wei Zhang; Mutsuyo Yamaguchi; Hiroyuki Aburatani; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

4.  Expression patterns of cytokine, growth factor and cell cycle-related genes after partial hepatectomy in rats with thioacetamide-induced cirrhosis.

Authors:  Shu Yang; Chon Kar Leow; Theresa May Chin Tan
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

5.  Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.

Authors:  E Nagababu; J G Mohanty; J S Friedman; J M Rifkind
Journal:  Free Radic Res       Date:  2013-01-09

6.  Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure.

Authors:  James W Dear; Asada Leelahavanichkul; Angel Aponte; Xuzhen Hu; Stephanie L Constant; Stephen M Hewitt; Peter S T Yuen; Robert A Star
Journal:  Crit Care Med       Date:  2007-10       Impact factor: 7.598

7.  Corn peptides protect against thioacetamide-induced hepatic fibrosis in rats.

Authors:  Jie Lv; Zhi-Kui Nie; Jiu-Liang Zhang; Feng-Yan Liu; Zhen-Zhen Wang; Zhi-Li Ma; Hui He
Journal:  J Med Food       Date:  2013-09-24       Impact factor: 2.786

Review 8.  The role of toxicoproteomics in assessing organ specific toxicity.

Authors:  B Alex Merrick; Frank A Witzmann
Journal:  EXS       Date:  2009

9.  Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis.

Authors:  Haralabos C Karantonis; Georgios Gribilas; Ioannis Stamoulis; Constantinos Giaginis; Chara Spiliopoulou; Gregorios Kouraklis; Constantinos Demopoulos; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

10.  Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients.

Authors:  Yoshiyuki Takahara; Mitsuo Takahashi; Qing-Wei Zhang; Hirotaka Wagatsuma; Maiko Mori; Akihiro Tamori; Susumu Shiomi; Shuhei Nishiguchi
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.